The medical sector is a vast field comprising numerous stocks, each vying for investor attention. Among these, McKesson Corporation (NYSE:MCK) has emerged as a notable performer, drawing interest due to its impressive returns. This article delves into McKesson's performance relative to its sector peers to assess its standing.
McKesson operates within the Medical sector, which includes a total of 916 individual stocks. This sector currently holds a Zacks Sector Rank of #11. The Zacks Sector Rank is a tool that evaluates 16 different groups by measuring the average Zacks Rank of the stocks within each sector, providing a gauge of their relative strength.
The Zacks Rank is a widely recognized stock-rating system that places emphasis on earnings estimates and revisions, aiming to identify stocks with improving earnings outlooks. This system has a long-standing record of success, often highlighting stocks that outperform the market over the next one to three months. McKesson is currently assigned a Zacks Rank of #2 (Buy).
Over the past three months, the Zacks Consensus Estimate for McKesson's full-year earnings has increased by 1%. This upward revision reflects a positive shift in analyst sentiment and suggests an improving earnings outlook.
Recent data indicates that McKesson's stock has appreciated by approximately 11% on a year-to-date basis. In contrast, the average return for companies within the Medical sector is approximately 0.1%. This comparison underscores McKesson's superior performance relative to its sector peers.
Another standout performer in the Medical sector is Avantor, Inc. (NYSE:AVTR), which has achieved a remarkable year-to-date return of 33.9%. Over the past three months, Avantor's consensus EPS estimate for the current year has risen by 2.9%, and the stock also holds a Zacks Rank of #2 (Buy).
McKesson is categorized within the Medical - Dental Supplies industry, a group that comprises 14 individual stocks and is currently ranked #107 in the Zacks Industry Rank. Stocks in this industry have gained approximately 3.8% so far this year, highlighting McKesson's outperformance in terms of year-to-date returns.
In contrast, Avantor is part of the Medical Services industry, which includes 70 stocks and is ranked #103. This industry has experienced a 3.4% increase so far this year, further emphasizing Avantor's strong performance.
The impressive performance of both McKesson and Avantor suggests that investors with an interest in the Medical sector should keep a close watch on these stocks. Their ability to outperform their respective industries and the broader sector highlights their potential as strong investment opportunities.
For investors seeking the latest stock recommendations from Zacks Investment Research, the firm offers a report titled "7 Best Stocks for the Next 30 Days," which can provide additional insights into potential investment opportunities.
McKesson and Avantor's strong performance in the Medical sector is indicative of their solid business strategies and positive market sentiment. As they continue to deliver impressive returns, investors may find these stocks to be valuable additions to their portfolios.
Footnotes:
- McKesson's stock has appreciated approximately 11% year-to-date. Source.
- Avantor, Inc. has achieved a year-to-date return of 33.9%. Source.
- The Medical sector includes 916 stocks and holds a Zacks Sector Rank of #11. Source.
Featured Image: Depositphotos @ hasloo